The changing epidemiology of invasive fungal infections: new threats.
The epidemiology of invasive fungal infections is currently at a crucial stage. Potentially fatal fungal strains are emerging that are resistant to many commonly used antifungal agents. It is therefore important to recognize and minimize the major risk factors associated with infection. This paper summarizes the key epidemiological data.
Maschmeyer
Georg
G
Department of Hematology and Oncology, Klinikum Ernst von Bergmann, Potsdam, Germany. gmaschmeyer@klinikumevb.de
D001228:Aspergillosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D002175:Candida / Q000472:pathogenicity; D002176:Candida albicans / Q000472:pathogenicity; D002177:Candidiasis / Q000097:blood* / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000401:mortality; D025141:Drug Resistance, Fungal; D006801:Humans; D015994:Incidence; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology / Q000401:mortality; D015995:Prevalence; D012307:Risk Factors; D020096:Zygomycosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology